A study conducted on NAFL and NASH biopsy specimens to assess the expression of FcγRIIb on LSECs reported a medium negative correlation between serum collagen type IV and hyaluronan with FcγRIIb expression (Ishikawa et al., 2019). This evidence concerns the gene FCGR2B and metabolic dysfunction-associated steatohepatitis.